Ro

PureTech Founded Entity Gelesis Receives $30 Million Plenity® Order from Ro

Retrieved on: 
Thursday, November 18, 2021
Science, Other Science, Biotechnology, Research, Pharmaceutical, Health, Fitness & Nutrition, Clinical Trials, Gelesis, Ro, PureTech Health, GELESIS, RO, PURETECH HEALTH

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (PureTech or the Company), a clinical-stage biotherapeutics company, announced today that its Founded Entity, Gelesis, Inc. (Gelesis) received a $30 million fully paid pre-order for the companys first commercial product for weight management, Plenity, from Ro, a leading U.S. direct-to-patient healthcare company.

Key Points: 
  • PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (PureTech or the Company), a clinical-stage biotherapeutics company, announced today that its Founded Entity, Gelesis, Inc. (Gelesis) received a $30 million fully paid pre-order for the companys first commercial product for weight management, Plenity, from Ro, a leading U.S. direct-to-patient healthcare company.
  • Plenity was initially made available through a beta launch in 2020, and demand quickly outpaced supply while Gelesis worked to construct a larger manufacturing facility.
  • Since then, Gelesis has sold as much product as it can make and nearly 70,000 people have started their weight management journey with Plenity through Ros platform.
  • Ro projects Plenity will have 1,500% YoY revenue growth (Dec. 2020 to Dec. 2021) and anticipates weight management will continue to be among the companys top treatment requests on the Ro platform.

Gelesis Receives $30 Million Plenity Order from Ro

Retrieved on: 
Thursday, November 18, 2021
Managed Care, Research, Other Health, Mobile, Wireless, Pharmaceutical, Data Management, Technology, Science, Biotechnology, Practice Management, Other Technology, Health, Other Science, Gelesis, Ro, GELESIS, RO

Gelesis announced today that leading U.S. direct-to-patient healthcare company Ro has placed a $30 million fully paid pre-order for the companys first commercial product for weight management, Plenity.

Key Points: 
  • Gelesis announced today that leading U.S. direct-to-patient healthcare company Ro has placed a $30 million fully paid pre-order for the companys first commercial product for weight management, Plenity.
  • Plenity was initially made available through a beta launch in 2020, and demand quickly outpaced supply while Gelesis worked to construct a larger manufacturing facility.
  • View the full release here: https://www.businesswire.com/news/home/20211118005288/en/
    Gelesis receives $30 million Plenity order from Ro, a leading U.S. direct-to-patient healthcare company.
  • Ro projects Plenity will have 1,500% YoY revenue growth (Dec. 2020 to Dec. 2021) and anticipates weight management will continue to be among the companys top treatment requests on the Ro platform.

New Survey from Gennev Reveals the Impact Menopause Has on Productivity in the Workplace

Retrieved on: 
Thursday, July 8, 2021
Managed care, General Health, Health, Other Health, Human development, Articles, Middle age, Endocrinology, Endocrine system, Menopause, Menstrual cycle, Senescence, Workplace, Ro, Telehealth, Dietitian

Gennev , a telehealth platform and community of women dedicated to menopause support, today released a survey that examines how menopause impacts the workplace environment and the ability of employees to perform their jobs.

Key Points: 
  • Gennev , a telehealth platform and community of women dedicated to menopause support, today released a survey that examines how menopause impacts the workplace environment and the ability of employees to perform their jobs.
  • 90% of women surveyed work full or part time and have menopause symptoms that negatively impact their productivity and interpersonal relationships at work.
  • Companies must find a way to retain their workers, specifically women in the various stages of menopause, if they want to be competitive.
  • Gennev provides telehealth practices with menopause certified OB/GYNs, coaching with registered dietitians, health and wellness products, community conversations, and free education.

Ro Acquires Kit to Expand At-Home Diagnostics and Preventative Care Capabilities

Retrieved on: 
Wednesday, June 30, 2021
Ro

NEW YORK, June 30, 2021 /PRNewswire/ -- Ro , the healthcare technology company, today announced the acquisition of at-home diagnostics company Kit .

Key Points: 
  • NEW YORK, June 30, 2021 /PRNewswire/ -- Ro , the healthcare technology company, today announced the acquisition of at-home diagnostics company Kit .
  • Zachariah Reitano, co-founder and CEO of Ro, said, "With Kit, we are adding another essential piece to our vertically-integrated primary care platform.
  • Ro's vertically-integrated primary care platform powers a personalized, end-to-end healthcare experience from diagnosis, to delivery of medication, to ongoing care.
  • Ro also provides its patient-centric solutions including Workpath, its in-home care API, and Kit, its at-home diagnostic testing service, to other healthcare companies.

Revibe Men's Health Announces New Provider, Josephine R. Salazar, to Join San Antonio Location

Retrieved on: 
Monday, June 28, 2021
Microsoft, Medical specialties, Human sexuality, Andrology, Psychiatric diagnosis, Men's Health, Testosterone, msn, Windows Mobile software, Erectile dysfunction, Ro

HONOLULU, June 28, 2021 /PRNewswire/ --Revibe Men's Health, a men's health and wellness center with locations across the US, today announced that Josephine R. Salazar MSN, AGPCNP-BC, has been hired as the Health Care Provider in its San Antonio location.

Key Points: 
  • HONOLULU, June 28, 2021 /PRNewswire/ --Revibe Men's Health, a men's health and wellness center with locations across the US, today announced that Josephine R. Salazar MSN, AGPCNP-BC, has been hired as the Health Care Provider in its San Antonio location.
  • Revibe Men's Health announced that Josephine R. Salazar MSN, AGPCNP-BC, has joined its San Antonio location.
  • At Revibe Men's Health, Josephine will work with patients to optimize treatment plans for erectile dysfunction and low-testosterone that can help them perform in all aspects of their lives.
  • Her extensive background in men's health and expertise will help strengthen Revibe's offerings," said Dr. Michael Krychman, Chief Medical Officer of Revibe Men's Health.

Creator Platform Happs Raises $4.7 Million in Post-Seed Funding Round for Simultaneous Broadcasting

Retrieved on: 
Thursday, June 24, 2021
Ro

LOS ANGELES, June 24, 2021 (GLOBE NEWSWIRE) -- Happs, the community-driven live video platform for independent creators, has raised a $4.7 million post-seed funding round led by Bullpen Capital.

Key Points: 
  • LOS ANGELES, June 24, 2021 (GLOBE NEWSWIRE) -- Happs, the community-driven live video platform for independent creators, has raised a $4.7 million post-seed funding round led by Bullpen Capital.
  • The round included participation from Crosslink, Goodwater and Corazon, who led Happss seed round, and brings total funding to date to $6.2 million.
  • Rob Hayes of First Round Capital and former Instagram head of growth Bangaly Kaba also participated in the round.
  • Happs seamlessly allows creators to broadcast their best content and meet their fans how they want to be met, said Happs CEO and co-founder Mark Goldman.

BlueCity's He Health to introduce online consultation services and expand PEP delivery network

Retrieved on: 
Monday, June 21, 2021
Clinical medicine, Medicine, Medical specialties, Ejaculation, Male genital disorders, HIV/AIDS, Post-exposure prophylaxis, Prevention of HIV/AIDS, Premature ejaculation, Ro, Blued

BEIJING, June, 21, 2021 /PRNewswire/ --BlueCity(Nasdaq: BLCT) today announced thatHe Health, the brand's health service platform for men, will introduce comprehensive online consultation services and expand its PEP (post-exposure prophylaxis) express delivery network in the second half of this year.

Key Points: 
  • BEIJING, June, 21, 2021 /PRNewswire/ --BlueCity(Nasdaq: BLCT) today announced thatHe Health, the brand's health service platform for men, will introduce comprehensive online consultation services and expand its PEP (post-exposure prophylaxis) express delivery network in the second half of this year.
  • It also enables He Health to provide a more complete set of health services from men's health consultations to advice on issues like Erectile Dysfunction, Premature Ejaculation, HIV testing and prevention, and more, as well as drug accessibility services.
  • Meanwhile, coverage for the two-hour PEP delivery services during working hours will be extended from 40 cities to 100 in China by the end of this year.
  • BlueCity's mobile app Blued enables users to conveniently and safely connect with each other, express themselves and access professional health-related services.

Telehealth Utilization Continues to Fall Nationally from February to March 2021

Retrieved on: 
Tuesday, June 8, 2021
Articles, Technology, Assistive technology, Health informatics, Science and technology, Telehealth, Ro, Telemedicine

NEW YORK, June 8, 2021 /PRNewswire/ -- From February to March 2021, telehealth utilization continued a national decrease that began the previous month, but this time at a slower rate, according to FAIR Health's Monthly Telehealth Regional Tracker .

Key Points: 
  • NEW YORK, June 8, 2021 /PRNewswire/ -- From February to March 2021, telehealth utilization continued a national decrease that began the previous month, but this time at a slower rate, according to FAIR Health's Monthly Telehealth Regional Tracker .
  • From February to March 2021, telehealth utilization continued a national decrease that began the previous month.
  • Telehealth utilization expanded greatly in 2020, as patients and providers sought a venue of care that would reduce the chance of transmitting COVID-19.
  • This trend was consistent with a continuing rise, nationally and in every region, in the percentage of telehealth claim lines associated with mental health conditions, the number one telehealth diagnosis.

How Matias Reinhardt's RevoOptics is disrupting the American Eyeglass Industry

Retrieved on: 
Tuesday, June 1, 2021
Eyewear, Corrective lenses, Ophthalmology, Protective gear, Private equity, Economy, Glasses, Venture capital, Aboriginal-based organized crime, Ro, Equipment, Consumer goods

This is what has inspired 25-year-old Matias Reinhardt, ABOC to cofound RevoOptics along with 23-year-old James Ryan Herrera, ABOC.

Key Points: 
  • This is what has inspired 25-year-old Matias Reinhardt, ABOC to cofound RevoOptics along with 23-year-old James Ryan Herrera, ABOC.
  • With a range of eyeglass designs to suit every personality, their frames are available for as low as $125.
  • For its retail expansion plans, Matias is counting on "approaching venture capitalists for the first round of seed funding."
  • With this in mind, RevoOptics is striving to help Americans see better without "breaking an arm" on purchasing their eyeglasses.

LifeMD to Present at Upcoming June Investor Conferences

Retrieved on: 
Friday, May 28, 2021
Articles, Health informatics, Technology, Science and technology, Assistive technology, Telehealth, Ro, Telemedicine

NEW YORK, May 28, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company, today announced that management will present at the Capital Peak Advisors Best Ideas Conference and the 2021 LD Micro Invitational XI.

Key Points: 
  • NEW YORK, May 28, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company, today announced that management will present at the Capital Peak Advisors Best Ideas Conference and the 2021 LD Micro Invitational XI.
  • LifeMD will also host 1x1 meetings around the conference presentations.
  • LifeMD's telemedicine platform enables virtual access to affordable and convenient medical treatment from licensed providers and, when appropriate, prescription medications and over-the-counter products delivered directly to the patient's home.
  • All forward-looking statements attributable to LifeMD, Inc. or a person acting on its behalf are expressly qualified in their entirety by this cautionary language.